TABLE 1.
The twenty-one genes considered in the simulation studies.
| No. | Chromosome | Gene | q 1 | q 2 |
| 1 | 1 | GNB1 | 15 | 10 |
| 2 | 5 | LOC102467217 | 7 | 1 |
| 3 | 4 | PDE5A | 11 | 1 |
| 4 | 11 | C11orf48 | 2 | 2 |
| 5 | 1 | CTTNBP2NL | 5 | 2 |
| 6 | 9 | PTCH1 | 12 | 3 |
| 7 | 9 | SLC25A25 | 4 | 3 |
| 8 | 17 | CCL15-CCL14 | 9 | 4 |
| 9 | 6 | CD164 | 7 | 4 |
| 10 | 11 | IGSF22 | 10 | 5 |
| 11 | 3 | CRBN | 9 | 5 |
| 12 | 12 | VAMP1 | 5 | 6 |
| 13 | 19 | CLEC17A | 7 | 6 |
| 14 | 5 | DMGDH | 21 | 7 |
| 15 | 6 | LPA | 24 | 7 |
| 16 | 15 | CD276 | 7 | 8 |
| 17 | 12 | MED13L | 19 | 8 |
| 18 | 3 | KBTBD12 | 22 | 9 |
| 19 | 6 | HLA-DQB2 | 19 | 9 |
| 20 | 5 | GM2A | 12 | 10 |
| 21 | 13 | LRRC63 | 20 | 10 |
The information contains the chromosome, gene id, number of SNVs ((q1)), and number of CNV segments ((q2)). Some variants in the first gene, GNB1, are taken as the causal variants in all simulation settings except A1.